How to Successfully Extend the Cash Runway to Growth in Early Commercial Stage Life Science Companies
By Andrew Levitch, Patrick Nugent
This article is the second in a 4-part series reviewing financing solutions for the Life Science sector. Life Science venture capital and private equity-funded startups are constantly chasing capital to extend operating cash runways, driving value inflection milestones such as clinical trial data and funding growth for commercial-stage entities. Understandably,…Read More
Read MorePlanning a Medical Device Business is Not for the Faint of Heart
By Greg Johnstone
Creating a business plan for a medical device company is a complex challenge, even for the most experienced founder and management team. A medical device business must contend with many of the same issues that face other technology-driven businesses. These include difficult engineering challenges, fundamental physical or biological constraints, complex…Read More
Read MoreThe Startup’s Dilemma: Planning for Success vs. Conserving Cash
By Andrew Levitch
Having spent the past 12 years as a Life Sciences and Technology CFO consulting to venture and private-equity backed companies, I have seen a consistent and recurring dilemma faced by these emerging companies: the struggle between planning for success and conserving cash. The age-old adage “you have to spend money…Read More
Read MoreA Mentor’s Advice for CFOs: How to Help Clients Navigate Their Way to Success
By Jonathan Wolter
In my 45+ year career, I have been fortunate to be CFO at a number of technology and life science companies ranging in size from early stage to those with mature operations, private and public, including SmartRent, PARC, Vera Therapeutics, Amyris, Soleno Therapeutics, and Kyverna Therapeutics, among others. Over the…Read More
Read More